BEIJING (dpa-AFX) - China Biologic Products Holdings, Inc. (CBPO), a fully integrated plasma-based biopharmaceutical company in China, said its board has appointed Joseph Chow as the CEO, effective August 5, 2019. Chow has been a member of the Board since November 2014, and acting CEO since May 2019. He will continue to serve as a director and the Chairman.
The company noted that Chow has resigned from all positions he previously held at Centurium Capital. Chow no longer holds any interest in Centurium Capital.
Copyright RTT News/dpa-AFX
CHINA BIOLOGIC PRODUCTS-Aktie jetzt für 0€ handeln - auf Smartbroker.de